Important key points were assessed in their last studies since the authors were able to report those Gal9+ NPC derived SEVs to be selectively detected in plasma samples of NPC patients and mice xenograft with NPC tumours. The gene discussed is LGALS9; the disease is nasopharyngeal carcinoma.